Conditions: Atherosclerotic Coronary Vascular Disease
Keywords: Cardiovascular disease Exercise Treadmill Test Ranolazine Angina Myocardial ischemia
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 14
Healthy volunteers: no

Brief summary:
The study was designed to evaluate the use of ETT electrocardiogram (ECG) indices as biomarkers in the assessment of atherosclerotic coronary vascular disease (ASCVD).

Detailed description:

Arms:
arm 1: Participants received ranolazine 500 milligrams (mg), orally, twice daily (b.i.d.) up to 14 days.

Interventions: intervention 1: Ranolazine 500 mg
Intervention descriptions: intervention 1: Ranolazine 500 mg, oral tablet, b.i.d.

Protocol document: